Johnson Financial Group Inc (Wisconsin)’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92K Hold
33
﹤0.01% 772
2026
Q1
$1.92K Hold
33
﹤0.01% 794
2025
Q4
$1.52K Hold
33
﹤0.01% 849
2025
Q3
$1.19K Buy
+33
New +$1.09K ﹤0.01% 997

Other funds holding PCVX

Johnson Financial Group Inc (Wisconsin)'s PCVX Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Vaxcyte (PCVX) position steady in Q2 2026 at 33 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Johnson Financial Group Inc (Wisconsin) first reported a position in PCVX in Q3 2025 and has held it in 4 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 33 shares of Vaxcyte worth $1.92K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #772 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Vaxcyte in Q3 2025 and has held it in 4 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.